<DOC>
	<DOCNO>NCT00822991</DOCNO>
	<brief_summary>The aim study prove usefulness contrast-enhanced ultrasound ( CE-US ) use Sonazoid ( TM ) early detection HCC compare conventional B-mode ultrasound ( B-mode US ) hepatitis virus relate cirrhosis , define super high-risk patient hepatocarcinogenesis , Furthermore , analyze whether early detection HCC CE-US survival benefit B-mode US .</brief_summary>
	<brief_title>Sonazoid Enhanced Liver Cancer Trial Early Detection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>1 . Age 20 2 . HBV HCV relate liver cirrhosis 3 . No history HCC 4 . Diagnosed liver cirrhosis histologically clinically Histologically confirm liver biopsy Confirmed formula diagnose cirrhosis Radiological finding Finding portal hypertension Platelet &lt; 130,000 5 . Inpatient outpatient 6 . Patients sign write informed consent form 1 . History hypersensitivity egg yolk 2 . Pregnant lactate woman woman may pregnant 3 . Severe liver dysfunction ( AST , ALT , BIL level &gt; 10ULN 4 . Associated HCC 5 . Patients receive interferon 6 . Age 20 7 . Judged investigator appropriate inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Sonazoid</keyword>
	<keyword>Early detection</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Liver cirrhosis</keyword>
</DOC>